ROIVW (Roivant Sciences) OCF Margin %: -6,500.71% (As of Mar. 2026)


ROIVW Roivant Sciences Ltd ROIVW
55 GF Score
Price $2.75
! 7 Warning Signs
View Full Analysis

What is Roivant Sciences OCF Margin %?

Roivant Sciences ROIVW -3.85% 55 OCF Margin % is -6,500.71% as of Mar. 2026. GuruFocus rates ROIVW with a GF Score™ of 55/100. The stock has 7 warning signs investors should review. Among 959 Biotechnology companies, Roivant Sciences ranks worse than 93.74% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Roivant Sciences's Cash Flow from Operations for the three months ended in Mar. 2026 was $-163.82 Mil. Roivant Sciences's Revenue for the three months ended in Mar. 2026 was $2.52 Mil. Therefore, Roivant Sciences's OCF Margin % for the quarter that ended in Mar. 2026 was -6,500.71%.

As of today, Roivant Sciences's current OCF Yield % is -3.06%.

The historical rank and industry rank for Roivant Sciences's OCF Margin % or its related term are showing as below:


During the past 6 years, the highest OCF Margin % of Roivant Sciences was -1225.86%. The lowest was -9084.13%. And the median was -2507.12%.

ROIVW's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Roivant Sciences OCF Margin % Related Terms

Roivant Sciences OCF Margin % Historical Data

* Premium members only.

The historical data trend for Roivant Sciences's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roivant Sciences OCF Margin % Chart

Roivant Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
Get a 7-Day Free Trial -1,225.86 -2,674.89 -2,339.34 -2,889.38 -9,084.13

Roivant Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,279.59 -9,418.57 -11,818.20 -9,829.11 -6,500.71
ROIVW
55GF Score
Roivant Sciences Ltd ROIVW
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Roivant Sciences OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Roivant Sciences's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-750.349/8.26
=-9,084.13 %

Roivant Sciences's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-163.818/2.52
=-6,500.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -6,500.71% mean?
Roivant Sciences (ROIVW) has a OCF Margin % of -6,500.71% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Roivant Sciences and its competitors. According to the industry distribution chart, Roivant Sciences ranks #899 out of 959 companies in the Biotechnology industry, placing it in the top 93.7%.
Is Roivant Sciences' OCF Margin % too high?
Roivant Sciences' current OCF Margin % is -6,500.71%. Based on the distribution chart, Roivant Sciences ranks #899 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Roivant Sciences has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Roivant Sciences' OCF Margin % compare to INSM and INCY?
According to the Biotechnology industry distribution chart, Roivant Sciences ranks #899 out of 959 companies for OCF Margin %. This places Roivant Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Roivant Sciences and its competitors. Roivant Sciences's current OCF Margin % is -6,500.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roivant Sciences stock overvalued right now?
Roivant Sciences (ROIVW) has a current OCF Margin % of -6,500.71%. The current OCF Margin % is -6,500.71%. Roivant Sciences' overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Roivant Sciences (ROIVW), the current OCF Margin % is -6,500.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Roivant Sciences Business Description

Other Exchanges ROIV:USA87S:Germany
Address 50 Broadway, 7th Floor, London, GBR, SW1H 0BD
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
55GF Score

Get the complete analysis for ROIVW

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.75
Price